Home » Stocks » Intercept Pharmaceuticals » Financials » Income Statement

Intercept Pharmaceuticals, Inc. (ICPT)

Stock Price: $47.09 USD 0.57 (1.23%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Intercept Pharmaceuticals Income Statement (Annual)

The table below shows the annual income statements for Intercept Pharmaceuticals stock for the past 10 years.

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010
Revenue25218013124.952.781.741.622.451.81-
Revenue Growth40.15%37.3%424.85%796.87%59.7%7.4%-33.69%35.51%--
Cost of Revenue4.212.521.37-------
Gross Profit24817713024.952.781.741.622.451.81-
Selling, General & Admin31725527427411934.6013.135.184.213.64
Research & Development24320719115411380.3127.9416.1811.4312.71
Operating Expenses56046346542723211541.0721.3615.6416.35
Operating Income-312-285-336-403-229-113-39.45-18.91-13.83-16.35
Interest Income/Expense41.1430.5229.2714.20------
Other Expense/Income32.2523.7524.7610.29-2.7317028.3424.73-1.09-1.27
Net Income-345-309-360-413-226-283-67.79-43.64-12.74-15.09
Shares Outstanding31.6528.4625.0524.6623.6920.7818.036.283.333.33
Shares Change11.21%13.61%1.59%4.09%14%15.28%186.94%88.7%0%-
EPS (Basic)-10.89-10.86-14.38-16.74-9.56-13.63-3.76-7.36-4.73-5.40
Earnings Per Share (EPS)-10.89-10.86-14.38-16.74-9.56-13.63-3.76-7.36-4.73-5.40
FCF Per Share-7.51-8.46-11.01-14.09-7.13-4.45-1.64-2.510.76-4.11
Gross Margin98.3%98.6%99%100%100%100%100%100%100%-
Operating Margin-124.0%-158.8%-256.3%-1,613.3%-8,237.1%-6,496.6%-2,432.3%-773.2%-766.2%-
Profit Margin-136.8%-172%-275.2%-1654.6%-8139.1%-16258.7%-4179.5%-1891.7%-871.8%-
FCF Margin-94.3%-134.0%-210.6%-1,392.8%-6,068.9%-5,303.2%-1,827.1%-645.4%140.9%-
EBITDA-294-274-326-395-225-283-67.69-43.44-12.33-14.61
EBITDA Margin-116.9%-152.5%-249.3%-1582.3%-8078.3%-16233.2%-4173%-1776%-682.9%-
EBIT-304-279-331-399-226-283-67.79-43.64-12.74-15.09
EBIT Margin-120.5%-155.0%-252.8%-1,597.7%-8,139.1%-16,258.7%-4,179.5%-1,784.2%-705.6%-